Steven C Quay insider trades: Atossa Therapeutics (ATOS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Steven reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 21, 2025 | ATOS | ↑ Buy | 11,239 | $0.88 | $10K | Direct | May 22, 2025 (1d) |
| Mar 9, 2016 | ATOS | ↑ Buy | 15,000 | $0.37 | $6K | Indirect | Mar 10, 2016 (1d) |
| Feb 16, 2016 | ATOS | ↑ Buy | 15,000 | $0.53 | $8K | Indirect | Feb 17, 2016 (1d) |
| Jan 19, 2016 | ATOS | ↑ Buy | 50,000 | $0.20 | $10K | Indirect | Jan 21, 2016 (2d) |
| Oct 1, 2013 | ATOS | ↓ Sell | 7,265 | $5.66 | $41K | By Ensisheim Partners, LLC | Oct 3, 2013 (2d) |
| Sep 27, 2007 | NSTK | ↓ Sell | 5,200 | $13.63 | $71K | Direct | Sep 28, 2007 (1d) |
| Jul 25, 2007 | NSTK | ↓ Sell | 5,800 | $12.21 | $71K | Direct | Jul 27, 2007 (2d) |
| Jun 7, 2007 | NSTK | ↓ Sell | 6,400 | $11.08 | $71K | Direct | Jun 8, 2007 (1d) |
| Apr 18, 2007 | NSTK | ↓ Sell | 5,850 | $12.03 | $70K | Direct | Apr 20, 2007 (2d) |
| Feb 27, 2007 | NSTK | ↓ Sell | 6,130 | $11.50 | $70K | Direct | Mar 1, 2007 (2d) |
| Jan 25, 2007 | NSTK | ↓ Sell | 5,250 | $13.44 | $71K | Direct | Jan 26, 2007 (1d) |
| Nov 15, 2006 | NSTK | ↓ Sell | 3,620 | $19.52 | $71K | Direct | Nov 17, 2006 (2d) |
| Oct 9, 2006 | NSTK | ↓ Sell | 5,175 | $15.61 | $81K | Direct | Oct 10, 2006 (1d) |
| Aug 8, 2006 | NSTK | ↓ Sell | 5,820 | $13.87 | $81K | Direct | Aug 8, 2006 (0d) |
| Jun 15, 2006 | NSTK | ↓ Sell | 5,540 | $14.57 | $81K | Direct | Jun 15, 2006 (0d) |
| Apr 25, 2006 | NSTK | ↓ Sell | 5,100 | $15.76 | $80K | Direct | Apr 27, 2006 (2d) |
| Apr 11, 2006 | NSTK | ↓ Sell | 2,667 | $15.83 | $42K | By spouse | Apr 12, 2006 (1d) |
| Mar 16, 2006 | NSTK | ↓ Sell | 4,950 | $16.24 | $80K | Direct | Mar 17, 2006 (1d) |
| Jul 11, 2005 | NSTK | ↓ Sell | 54,154 | $15.12 | $819K | Direct | Jul 13, 2005 (2d) |
| Jul 5, 2005 | NSTK | ↓ Sell | 232,000 | $14.03 | $3.3M | Direct | Jul 7, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Steven C Quay's insider trades
Steven C Quay is President & CEO at Atossa Therapeutics (ATOS). Since Jul 5, 2005, Steven has reported 4 open-market purchases worth $33K and 16 sales worth $5.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (21 filings), other transactions (3 filings), option exercises (3 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATOS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.